References
- Ahmed, T., Long, T. N., Huong, P. T., & Stewart, D. E. (2015). Drug injecting and HIV risk among injecting drug users in Hai Phong, Vietnam: A qualitative analysis. BMC Public Health, 15(1), 32. http://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-015-1404-3 doi: 10.1186/s12889-015-1404-3
- Cook, C., Bridge, J., McLean, S., Phelan, M., & Barrett, D. (2014). The funding crisis for harm reduction: Donor retreat, government neglect and the way forward. Retrieved from http://www.ihra.net/files/2014/09/22/Funding_report_2014.pdf
- Des Jarlais, D. C., Arasteh, K., & Friedman, S. R. (2011). HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years. Substance Use and Misuse, 46(2–3), 131–139. doi:10.3109/10826084.2011.521456
- El-Bassel, N., Shaw, S. A., Dasgupta, A., & Strathdee, S. A. (2014). Drug use as a driver of HIV risks: Re-emerging and emerging issues. Current Opinion in HIV and AIDS, 9(2), 150–155. doi: 10.1097/COH.0000000000000035
- EMCDDA. (2010). Harm reduction: Evidence, impacts and challenges. Retrieved from Lisbon http://www.emcdda.europa.eu/publications/monographs/harm-reduction
- Heckathorn, D. (1997). Respondent-driven sampling: A new approach to the study of hidden populations. Social Problems, 44(2), 174–199. doi: 10.2307/3096941
- Heckathorn, D. (2002). Respondent-driven sampling II: Deriving valid population estimates from chain-referral samples of hidden populations. Social Problems, 49(1), 11–34. doi: 10.1525/sp.2002.49.1.11
- Iguchi, M. Y., Ober, A. J., Berry, S. H., Fain, T., Heckathorn, D., Gorbach, P. M., & Shoptaw, S. (2009). Simultaneous recruitment of drug users and men who have sex with men in the United States and Russia using respondent-driven sampling: Sampling methods and implications. Journal of Urban Health, 86(1), 5–31. doi: 10.1007/s11524-009-9365-4
- Kamarulzaman, A., & McBrayer, J. L. (2015). Compulsory drug detention centers in East and Southeast Asia. International Journal of Drug Policy, 26, S33–S37. doi: 10.1016/j.drugpo.2014.11.011
- Kato, M., Granich, R., Bui, D. D., Tran, H. V., Nadol, P., Jacka, D., & Lo, Y. R. (2013). The potential impact of expanding antiretroviral therapy and combination prevention in Vietnam: Towards elimination of HIV transmission. JAIDS Journal of Acquired Immune Deficiency Syndromes, 63(5), e142–e149. doi: 10.1097/QAI.0b013e31829b535b
- Marshall, Z., Dechman, M., Minichiello, A., Alcock, L., & Harris, G. (2015). Peering into the literature: A systematic review of the roles of people who inject drugs in harm reduction initiatives. Drug and Alcohol Dependence, 1(151), 1–14. doi: 10.1016/j.drugalcdep.2015.03.002
- Montaner, J., Yip, L. V. D., Day, B., Gustafson, I., Tarrios, R., Kerr, R., & Kendall, P. (2012). Expanded HAART coverage is associated with decreased HIV/AIDS morbidity and HIV new diagnoses: An update on the ‘treatment as prevention’ experience in British Columbia, Canada. Paper presented at the International AIDS Conference, Washington D.C.
- Nguyan, T., Jouffret-Roustide, M., Huong, D., Pham, M., Oanh, K., Le, D., … Nagot, N. (2015). Social and health benefits of participating in HIV research with people who inject drugs: Experience of the drugs and infections in Vietnam-Initiation (DRIVE-IN) study in Vietnam. Paper presented at the Amsterdam AIDS Impact Conference, Amsterdam.
- Van den Berg, C., Smit, C., Van Brussel, G., Coutinho, R., & Prins, M. (2007). Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: Evidence from the Amsterdam Cohort Studies among drug users. Addiction, 102(9), 1454–1462. doi:10.1111/j.1360-0443.2007.01912.x
- Vickerman, P., Martin, N., Turner, K., & Hickman, M. (2012). Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings. Addiction, 107(11), 1984–1995. doi: 10.1111/j.1360-0443.2012.03932.x